相关实验视频
Updated: Jun 24, 2025

12:24
Murine Model of CD40-activation of B cells
Published on: March 5, 2010
12.7K
CD20表达调节B细胞淋巴瘤中的CD37水平 - 对免疫疗法的影响
Malgorzata Bobrowicz1, Aleksandra Kusowska1,2,3, Marta Krawczyk1,3,4
1Department of Immunology, Medical University of Warsaw, Warsaw, Poland.
Oncoimmunology
|June 7, 2024
概括
抗利图西马布淋巴瘤细胞显示CD37水平降低,影响抗CD37抗体的有效性. 然而,针对CD37的CAR T细胞疗法仍然有效,为侵袭性淋巴瘤提供了一个有希望的替代方案.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
背景情况:
- 淋巴瘤的第一线治疗方法,Rituximab加化学疗法 (R-CHOP),导致约40%的患者复发.
- 新的治疗策略对于治疗侵袭性淋巴瘤至关重要.
- 抗瑞图西马布 (RR) 细胞系可以作为研究对R-CHOP耐药机制的模型.
研究的目的:
- 为了研究CD37在利图西马布耐药性中的作用.
- 探索CD20和CD37.7之间的相互作用.
- 为了评估抗CD37免疫疗法的疗效在抗西马布和CD20淘汰赛模型中.
主要方法:
- 建立和表征抗西马布 (RR) 和CD20淘汰赛 (KO) 淋巴瘤细胞系.
- 分析CD37表达水平及其与CD20的相互作用.
- 对抗CD37单克隆抗体 (mAb) 疗效的评估,包括补剂依赖性细胞毒性 (CDC) 和内部化率.
- 对CD37导向的化学抗原受体 (CAR) T细胞活性的评估.
主要成果:
- RR细胞表现出显著的CD37.7下调.
- CD20和CD37形成一个复合体,CD20可能会在细胞膜上稳定CD37.
- 抗CD37 mAb介导的CDC在RR和CD20KO细胞中减小,通过溶酶体抑制部分恢复.
- 在CD20KO细胞中,抗CD37mAb内部化增加,这表明抗体-药物合物 (ADC) 的潜力.
- CD37导向的CAR T细胞疗效不受CD37下调的影响.
结论:
- 发现了一种涉及CD20相互作用的新型CD37调节机制.
- CD37下调影响抗CD37 mAb的疗效,但不影响CAR T细胞疗法.
- 这些发现为优化在淋巴瘤治疗中的抗CD37免疫疗法提供了洞察力.
相关概念视频
Tumor Immunotherapy
514
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
514
T Cell Activation and Clonal Selection
706
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
706
Cytotoxic T Cells-mediated Immune Response
891
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
891

